Chinook Therapeutics CVR
13F holders, Q1 2024 (March 31)4holders
$0.28avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Chinook Therapeutics CVR in their 13F filings. The largest holders were Erste Asset Management GmbH ($120K), Propel Bio Management, LLC ($31K) and Public Employees Retirement System of Ohio ($0).
- Company
- Chinook Therapeutics CVR
- CUSIP
- 169CVR016
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 4 holders
| Erste Asset Management GmbH | 0.00% | No change | 307,769 | $120K |
| Propel Bio Management, LLC | 0.02% | No change | 79,357 | $31K |
| Public Employees Retirement System of Ohio | 0.00% | No change | 60,000 | $0 |
| Rhumbline Advisers | 0.00% | No change | 89,822 | $0 |
"% of holder's portfolio" is CHINOOK THERAPEUTICS CVR's weight in each manager's 13F, not the share of Chinook Therapeutics CVR the manager owns.